Most of the current studies focus on the relationship between BRAF gene mutations and thyroid cancer, as well as factors related to prognosis, such as the relationship between BRAF mutations and thyroid cancer tumor invasion outside the perineum, lymph node metastasis, and pathological staging (Liu et al., 2014; Wang et al., 2016; Ma et al., 2020). This evidence concerns the gene BRAF and neoplasm.